IGFBP7 and left ventricular mass regression: a sub‐analysis of the EMPA‐HEART CardioLink‐6 randomized clinical trial

AIMS: Given recent suggestions that serum levels of insulin‐like growth factor‐binding protein 7 (IGFBP7) may identify patients who derive greater cardiorenal benefits from treatment with sodium‐glucose transport 2 inhibitors (SGLT2i), this exploratory sub‐analysis of the EMPA‐HEART CardioLink‐6 ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Puar, Pankaj, Mistry, Nikhil, Connelly, Kim A., Yan, Andrew T., Quan, Adrian, Teoh, Hwee, Pan, Yi, Verma, Raj, Hess, David A., Verma, Subodh, Mazer, C. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192263/
https://www.ncbi.nlm.nih.gov/pubmed/37038626
http://dx.doi.org/10.1002/ehf2.14335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192263/
https://www.ncbi.nlm.nih.gov/pubmed/37038626
http://dx.doi.org/10.1002/ehf2.14335

Ejemplares similares